The Justice Department on Tuesday sued to block UnitedHealth Group-owned Optum's proposed $3.3 billion acquisition of Amedisys, arguing the deal gives UNH too much power over home health and hospice.
Why it matters: If a trial proceeds, it will likely be the first health care antitrust case under a Trump administration.
